Promimic
16.25 SEK
+2.20 %
Less than 1K followers
PRO
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+2.20 %
+6.21 %
+6.91 %
-10.71 %
-27.78 %
-40.91 %
+39.25 %
-
-0.20 %
Promimic specializes in biotechnology. The company develops biocompatible surfaces for implants and conducts research in surface modifications. Examples of specialist areas include surface modifications for osseointegration for orthopedic and dental implants. The largest operations are in Europe and America, where research and development is conducted in-house but also through partners. Promimic is headquartered in Mölndal, Sweden.
Read moreMarket cap
307M SEK
Turnover
14.57K SEK
Revenue
43.98M
EBIT %
-18.92 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
24/2
2026
Annual report '25
19/5
2026
Interim report Q1'26
21/5
2026
General meeting '26
All
Press releases
ShowingAll content types
Valberedning utsedd i Promimic AB (publ)
Analyst Group: Analyst Group intervjuar Promimics VD Magnus Larsson
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools